L
Lineage Cell Therapeutics Inc
AMEX:LCTX
Lineage Cell Therapeutics Inc
AMEX:LCTX
Price:
1.25
USD
-4.58%
Market Closed
Market Cap:
$311.4m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
L
|
Lineage Cell Therapeutics Inc
AMEX:LCTX
|
US |
|
Aisan Industry Co Ltd
TSE:7283
|
JP |
|
ForFarmers NV
AEX:FFARM
|
NL |
|
M
|
Mosaic Co
F:02M
|
US |
|
E
|
Equitable Group Inc
OTC:EQGPF
|
CA |
|
R
|
Reading International Inc
F:46B
|
US |
|
P
|
Protean eGov Technologies Ltd
BSE:544021
|
IN |
|
Five Star Bancorp
F:4F6
|
US |
|
Paul Merchants Ltd
BSE:539113
|
IN |
|
O
|
Oracle Corp
DUS:ORC
|
US |
|
MRC Global Inc
NYSE:MRC
|
US |
|
P
|
Protean eGov Technologies Ltd
NSE:PROTEAN
|
IN |
|
JAFCO Group Co Ltd
TSE:8595
|
JP |
|
B
|
Bank Danamon Indonesia Tbk PT
XMUN:HX9
|
ID |
|
P
|
Pros Holdings Inc
F:PH2
|
US |
|
E
|
Enwave Corp
F:E4U
|
CA |
|
Medical Properties Trust Inc
NYSE:MPT
|
US |
|
Northeast Community Bancorp Inc
F:JY4
|
US |
|
J
|
John Wood Group PLC
OTC:WDGJF
|
UK |
|
O
|
Organovo Holdings Inc
F:4OR1
|
US |
|
A
|
Asana Inc
F:A6N
|
US |
Wall St Price Targets
LCTX Price Targets Summary
Lineage Cell Therapeutics Inc
Lineage Cell Therapeutics Inc
Wall Street analysts forecast LCTX stock price to rise over the next 12 months.
According to Wall Street analysts, the average 1-year price target for LCTX is 5.61 USD with a low forecast of 3.03 USD and a high forecast of 9.45 USD.
Lowest Forecast
Price Target
3.03
USD
142% Upside
Average Forecast
Price Target
5.61
USD
349% Upside
Highest Forecast
Price Target
9.45
USD
656% Upside
Why do you have more estimates than other sites?
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is LCTX's stock price target?
Price Target
5.61
USD
5.61
USD
According to Wall Street analysts, the average 1-year price target for LCTX is 5.61 USD with a low forecast of 3.03 USD and a high forecast of 9.45 USD.
What is the Revenue forecast for Lineage Cell Therapeutics Inc?
Projected CAGR
58%
58%
Over the last 14 years, the compound annual growth rate for Revenue has been 9%. The projected CAGR for the next 8 years is 58%.
